Issues

Volume 164 Issue 9

6 May 1996

Editorials Pregnancy outcomes of Australian Aboriginals and Torres Strait Islanders Michael C O'Connor, Alison Bush (MJA 1996; 164: 516)The cardiovascular state of Australia: good or bad news? Paul Magnus (MJA 1996; 164: 517)Migraine: then and now James W Lance (MJA 1996; 164: 519)Nurses in Australia: their role today and tomorrow Elizabeth C Percival, Helen M Hamilton (MJA 1996; 164: 520) Research Pregnancy outcomes in urban Aboriginal women Caroline de Costa, Andrew Child (MJA 1996; 164: 523)Anxiety and depression in general practice patients: prevalence and management Mark F Harris, Derrick Silove, Eva Kehag, Alex Barratt, Vija Manicavasagar, Jocelyn Pan, John F Frith, Alex Blaszczynski, C Dimity Pond (MJA 1996; 164: 526)Preventing falls in the elderly at home: a community-based program Peter G Thompson (MJA 1996; 164: 530)Correction: Where the national research dollar goes. Allocation of NHMRC resources to clinical categories, 1989-1995 Walter L Giusti, Neale A Yates, John G McDougall (MJA 1996; 164: 532) Health Care Reuse of single-use medical devices: National Health and Medical Research Council deliberations Christopher W Brook (MJA 1996; 164: 537) Reuse of single-use medical devices: who makes the decision? Keith Woollard (MJA 1996; 164: 538) Managing HIV HIV and Kaposi's sarcoma Jeremy L Millar, David Goldstein, Karen A Gelmon (MJA 1996; 164: 539)HIV and non-tuberculous mycobacterial infection Jennifer F Hoy, Deborah Marriott, Tom Gottlieb (MJA 1996; 164: 543)HIV and bacterial infections Anthony M Allworth, Frank J Bowden (MJA 1996; 164: 546)HIV, weight loss and wasting syndrome Mark D Kelly, Andrew R Lloyd, Richard J Kemp (MJA 1996; 164: 549)Recommendations for antimicrobial prophylaxis in HIV Anne M Mijch, John Quin (MJA 1996; 164: 551) MJA Practice Essentials - Dermatology Tinea of the skin, hair and nails Orli Wargon (MJA 1996; 164: 552) Milestones Australian nursing: traditions and transitions Marian P Borland (MJA 1996; 164: 557) ADRAC Selective serotonin reuptake inhibitors and SIADH MJA 1996; 164: 562)

Editorials

Neurology 6 May 1996 Free

Migraine: then and now

Editorial Migraine: then and now Better understanding of the neurobiology of migraine is leading to better treatment MJA 1996; 164: 519-520 Migraine is debilitating for its victims and frustrating for their friends and relatives. The Australian National Health Survey of 57 000 people in 1989-1990 found that 12.2% had experienced a headache in the preceding two weeks.1 Extrapolation to the entire Australian population implies that 280 000 people suffered a migraine attack and two million some lesser form of headache in that two-week period. The annual cost of migraine to the community, considering loss of productivity and cost of medical services, has been estimated at $302-$721 million by the Centre for Applied Economic Research, University of New South Wales.2National Migraine Week (12-18 May) may help to increase public awareness of this problem. In addition, the Migraine Foundation, a subsidiary of the Australian Brain Foundation, has recently been established to promote education and to encourage research and the formation of self-help groups in the community. When is a headache a migraine? Whether migraine has a place at one end of a headache spectrum or is a separate entity remains controversial. The International Headache Society has established criteria for the diagnosis of migraine, to standardise headache classification for surveys and clinical trials.3The Classification Committee's general description of migraine is "an idiopathic headache disorder manifesting in attacks lasting 4-72 hours", with the characteristics of common unilateral location, pulsating quality, moderate or severe intensity, aggravation by physical activity and association with nausea and photophobia. Nevertheless, a third of migraine headaches are bilateral, and not all throb or are accompanied by nausea and photophobia. About 25% of those affected describe premonitory symptoms the night before -- a feeling of elation, craving for sweet foods or excessive yawning. Between 25% and 40% experience a visual aura at some time, but only 10% describe typical fortification spectra (zigzag visual hallucinations) or spreading scintillating scotomas. Such neurological symptoms usually precede the headache, but may occur without an ensuing headache or may appear while a headache is in progress. However, most migraine headaches occur without such symptoms. Varieties of migraine are designated hemiplegic, basilar, ophthalmoplegic or retinal, depending on the area of the brain rendered ischaemic. A migraine headache lasting longer than 72 hours is termed "status migrainosus". Neurological symptoms persisting for more than seven days indicate a migrainous infarction. Genetic factors contribute about half of the susceptibility to migraine, and the gene for some kinships with familial hemiplegic migraine has been localised to chromosome 19.4 Neurobiology of migraine Modern techniques have improved our knowledge of both aura and headache mechanisms. Aura: Regional cerebral blood flow studies show a reduction in cortical perfusion, starting in the parieto-occipital region during a visual aura and spreading forward at 2-3 mm/min. This corresponds to the speed at which fortification spectra appear to move over the field of vision and that of "spreading cortical depression" observed by Leâo as an artefact in experimental animals in the 1940s.5 Recently, magnetic resonance imaging and positron emission tomography (PET) showed a similar spreading pattern of diminished metabolism in a patient with migraine with blurred vision but no classical aura.6 Although needing confirmation, this raises the possibility of cortical oligaemia in migraine attacks that lack an aura; this would account for the impaired vision, loss of concentration and poor memory that often accompany migraine headache. Headache pain: Since the work of Wolff and his colleagues in the 1940s and 1950s, dilatation of the superficial temporal artery and its branches has been regarded as the main cause of headache pain. However, recent studies have shown that this applies to only about a third of migraine patients. Measurements of velocity of blood flow with transcranial Doppler ultrasound have shown that the middle cerebral artery dilates during migraine headache and returns to normal when the headache resolves after the injection of sumatriptan.7 Cerebral oedema may also be a feature of some migraine attacks, as there have been two reports of skull defects bulging during the headache phase.8 "Neurogenic inflammation" (with extravasation of protein from dural vessels) has been implicated, brought about by release of vasodilator peptides, such as calcitonin gene-related peptide (CGRP) and substance P.9,10 This effect can be blocked by sumatriptan and dihydroergotamine. It is also possible that the blood-brain barrier breaks down during migraine headache, allowing access of drugs that are normally excluded. When sumatriptan is administered during the aura phase it does not prevent the ensuing migraine headache, despite its prompt action once headache is established, suggesting that it can enter the brain only after the headache starts. How can we link the initiating cerebral events and the vascular changes? Stimulation of the brainstem nuclei, locus coeruleus and raphe dorsalis has been shown in animals to alter both intracranial and extracranial blood flow.11 In humans, some patients with implanted electrodes which stimulate the periaqueductal grey matter or thalamus for relief of bodily pain have developed migraine-like headaches, some associated with visual symptoms.12 PET scans during and after migraine headache have shown increased metabolic activity in the region of the periaqueductal grey matter and locus coeruleus on the side of the migraine headache, which persisted after the headache.13 What has happened to the "serotonin story"? It is now thought that the discharge of serotonin (5-hydroxytryptamine, 5-HT) by platelets at the onset of migraine headache14 may reflect similar changes in the central nervous system, as serotonin plays a key role in pain control. Serotonin is also a potent vasoconstrictor in the cranial circulation. Increase in knowledge of the many 5-HT receptors has led to the synthesis of agents which act as agonists of these receptors. Prophylactic medications, such as pizotifen and methysergide, act predominantly on 5-HT2 receptors in the central nervous system. The newest antimigraine drug, sumatriptan, is a highly selective agonist of the D-subtype of 5-HT1 receptors. It constricts cranial arteries, interferes with the release of vasodilator peptides and may also have central actions (as yet unknown), if, as has been proposed, the blood-brain barrier breaks down during migraine headache. Already other 5-HT1D agonists, such as 311C90 (zolmitriptan) and MK462, are undergoing clinical trials for the management of migraine headache. Continued research on these drugs and on the receptor sites for serotonin and other neurotransmitters involved in the migraine syndrome promises new therapeutic avenues in the treatment of migraine. James W Lance Consultant Neurologist, Institute of Neurological Sciences Prince Henry and Prince of Wales Hospitals, Sydney, NSW Australian Bureau of Statistics. National Health Survey: summary of results. 1989-1990. Canberra: ABS, 1991. (Catalogue No. 4364.0.) Parry TG. The prevalence and costs of migraine in Australia. Centre for Applied and Economic Research working paper. Sydney: CAER, University of New South Wales, 1992. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 Suppl 7: 13-96. Merikangas KR. Sources of genetic complexity of migraine. In: Sandler M, Ferrari M, Harnett S, editors. Migraine: pharmacology and genetics. London: Chapman and Hall, 1996: 254-274. Leâo AAP. Spreading depression of activity in the cerebral cortex. J Neurophysiol 1944; 7: 359-390. Woods RP, Iacoboni M, Mazziotta JC. Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med 1994; 331: 1689-1692. Friberg L, Olesen J, Iversen HK, Sperling B. Migraine pain associated with middle cerebral artery dilatation: reversal by sumatriptan. Lancet 1991; 338: 13-17. Lance JW. Swelling at the site of a skull defect during migraine headache. J Neurol Neurosurg Psychiatry 1995; 59: 641. Moskowitz MA, Cutrer EM. Trigeminovascular system and migraine. Semin Headache Manage 1996; 1: 7-9. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993; 33: 48-56. Lance JW, Lambert GA, Goadsby PJ, Zagami AS. Contribution of experimental studies to understanding the pathophysiology of migraine. In: Sandler M, Collins GM, editors. Migraine: a spectrum of ideas. Oxford: Oxford University Press, 1990: 21-39. Raskin NH, Hosobuchi Y, Lamb S. Headache may arise from perturbation of brain. Headache 1987; 27: 416-420. Weiller C, May A, Limmroth V, et al. Brain stem activation in spontaneous human migraine attacks. Nature Med 1995; 1: 658-660. Anthony M, Hinterberger H, Lance JW. Serotonin in migraine and stress. Arch Neurol 1967; 16: 544-552. ©MJA 1999 © 1999 Medical Journal of Australia.

James W Lance

General medicine 9 September 1999 Free

Nurses in Australia: their role today and tomorrow

Editorial Nurses in Australia: their role today and tomorrow The old stereotypes are long gone and the new nurse is developing swiftly MJA 1996; 164: 520-521 May 12 is International Nurses' Day, in tribute to nurses and the role they play in delivering health care. In Australia, the nature of this role has changed significantly over the past three decades. The momentum for this change has come in response to forces from both within and without the profession: the women's movement of the 1970s dramatically altered expectations of work for this once almost totally female workforce;1 in the 1980s, tertiary education was introduced; and in the 1990s, nursing has not escaped the impact of deregulation of the labour market, multiskilling and the drive towards greater efficiency and productivity in the face of economic pressures. Impact of tertiary education Newly qualified nurses are now the product of a liberal education, quite different from the hospital-based education of the past. Indeed, all nurses have embraced the tertiary opportunities that the transfer of nurse education has provided. The demand for places to convert certificate or diploma qualifications to degrees remains strong in the 34 universities with faculties or schools of nursing in Australia.2 So, too, does the demand for places for graduate diplomas and higher degrees; about half the schools of nursing offer doctoral programs3 and the number of nurses who have gained doctorates is increasing. This has in turn led to the creation of more chairs of clinical nursing (18 as of March 1996, with more pending [Professor S McKinley, Secretary to the Australian Professors of Clinical Nursing Association, personal communication]). As well as providing education, universities have promoted and stimulated research that is contributing to the developing knowledge base for nursing practice. This work, together with hospital-based research and that of newly established nursing research centres, is crucial to the evolution of the nurse's role and to the provision of evidence-based care unique to nursing. In fact, increased scientific knowledge and resulting new technologies and treatment methods are increasing the complexity of nursing practice. And in the constant interplay between education and research, education to maintain and develop new practical skills has become a critical necessity. Other influences Influences apart from those of education and research have led to further developments in the role of nurses. At times, blurred boundaries with the roles of other health workers have resulted, with accompanying dilemmas. For example, economic forces have led to the increasing employment of less skilled workers who have taken on some of the work of nurses, mostly outside the regulatory framework that governs nurses -- grave questions about accountability and duty of care need to be answered. For example, to whom and for what are personal care attendants, with no knowledge of drugs, accountable in administering prescribed medications without supervision? Indeed, the general decline in resources and the restructuring of service delivery systems will continue to impact on the role of nurses. Advancing technology is also associated with yet-to-be-resolved legal and ethical dilemmas in the role of nurses (as for all health practitioners) -- dilemmas, such as euthanasia and assisted suicide, that are no longer remote but immediate and omnipresent. Expanding roles The expansion of the nurse's role is challenging the existing statutory limitations on nursing practice. For example, nurses in intensive care units are at the cutting edge of technological innovation and often undertake activities once thought to be the sole province of medical practitioners.4 Nurses in remote areas have long been expected to act outside the boundaries of the nurse's role and have articulated the case for an expanded role (e.g., the right to prescribe some medications or to order pathological tests).5,6 Further, nurses in women's health services in most States and Territories find the absence of such rights (including also the right to refer clients to specialist services) prevents delivery of optimal patient care.7 A review of existing nursing roles with new and expanded boundaries is almost complete in New South Wales.8 The Nurse Practitioner Review, sponsored by the New South Wales Health Department, started in November 1993 and has included 10 pilot projects to evaluate three models of nursing roles with expanded responsibilities: Nurse Practitioner Remote Area, Nurse Practitioner General Practice and Nurse Practitioner Area and District Health. Within the context of each practice, extra responsibilities include ordering diagnostic procedures, prescribing and receiving or making referrals. The scope that the nurse practitioner role offers for advanced practice in nursing is a major attraction for nurses. And, given the developments in their preparation and the growth of nursing knowledge, it is a role that nurses are ready to fulfil. Within the wider context of all health care professions, nurses wish to work collaboratively, as team members, and to be consulted about their views on people's health care needs. They wish to be acknowledged for the contribution they make to patient recovery and to maintaining people's health and for the care and support they give to the dying; nurses are arguably the health professionals most intimate with people's lives and they recognise their resulting position of privilege and trust. And, in the challenging climate of change continually impacting on so many aspects of the nursing role, at least one aspect will persist: nurses will continue to support the values of caring and comfort that have always underpinned their practice. Elizabeth C Percival Executive Director, Royal College of Nursing, Canberra, ACT Helen M Hamilton Project Officer, Royal College of Nursing, Canberra, ACT Beaumont M. The professional role of a national nursing organisation. In: Gray G, Pratt R, editors. Issues in Australian nursing 2. Melbourne: Churchill Livingstone, 1989; 247-261. Report of the national review of nurse education in the higher education sector: 1994 and beyond. Canberra: AGPS, 1994: 143. Royal College of Nursing, Australia. Directory of higher education nursing courses. Sydney: New Hobson Press, 1996. Bucknall T, Thomas S. Clinical decision making in critical care. Aust J Adv Nurs 1995; 13 (2): 10-17. Kreger A. Remote area nursing practice: a quest for education. Report to the Council of Remote Area Nurses Inc. CRANA, 1991: 57-60. Buckley P, Gray G. Across the spinifex: registered nurses working in rural and remote South Australia. Adelaide: School of Nursing, Flinders University, 1993: 143. New South Wales Health Department. Role and function of nurse practitioners in New South Wales. Discussion paper. Sydney: NSW Health, 1992: 7, 13-17. (NSW State Health Publication No. [NB] 93-120.) New South Wales Health Department. Nurse Practitioner Review Stage 2. Vol 2. Sydney: NSW Health, 1993. A1/1-A5/1-20. (NSW State Health Publication No. [NB] 93-120.) ©MJA 1999 © 1999 Medical Journal of Australia.

Elizabeth C Percival · Helen M Hamilton

Health care

General medicine 6 May 1996 Free

Reuse in sterile sites of single-use medical devices: how common is this in Australia?

Reuse in sterile sites of single-use medical devices: how common is this in Australia? Peter J Collignon, Elaine Graham and Dianne E Dreimanis This article was published in the 6 May issue of The Medical Journal of Australia. Readers may print a single copy for personal use. No further reproduction or distribution of the articles in whole or in part should proceed without the permission of the publisher. For copyright permission, contact the Australasian Medical Publishing Company See also articles by Brook and Woollard Abstract - Introduction - Methods - Questionnaire - Definitions of cleaning/sterilising - Examination of devices - Results - Discussion - Reuse of medical devices - Cleaning and sterilisation - Recommendations for reuse - Cross-infection - Costs and cost benefit - Acknowledgements - References - Author's Details Register to be notified of new articles by email - - ©MJA1996 Abstract Objectives: To determine to what extent Australian hospitals reuse in sterile sites medical devices labelled "single use only"; to assess the adequacy of cleaning and sterilising procedures before reuse; and to estimate the possible incidence of cross-infection and the costs of not reusing these devices. Design: A self-administered questionnaire survey. Setting: All Australian hospitals (419) with more than 45 beds and undertaking medical and surgical procedures. Methods: Questionnaires were sent to hospital infection control practitioners in 1994 requesting information about reuse in sterile sites of single-use medical devices, the extent of reuse, the cleaning and sterilising processes involved, and the reasons for reuse. Results: Responses were received from 168 hospitals (40%). Reuse occurred in 64 (38%), and another 33 hospitals had been reusing medical devices 12 months before our survey (i.e., 97/168 hospitals [58%] were either reusing them at the time of our survey or had been doing so 12 months previously). More large (> 300 beds) metropolitan public hospitals (9/14; 64%) reported reusing than did smaller (50/143; 41%) or private hospitals (15/47; 32%). At six of the 64 hospitals where reuse occurred, the process of cleaning and/or sterilisation of these devices was not satisfactory; from the information we received, both cleaning and sterilisation were satisfactory in only 38 hospitals (59%). Examination of the 14 most commonly reused devices showed that the structure of 13 of these may compromise cleaning (and therefore sterilisation). The main reason given for reuse was cost saving. Assuming a 2% prevalence of transmissible infections in blood, and an infection transmission risk of 1/500, we estimate that each year in Australia there may be 40 cases of cross-infection for every one million procedures performed with reused devices (0.004%). Conclusions: Reuse of medical devices labelled "single use only" is common in Australian hospitals. Most devices appear to be unsuitable for reuse. Complete cessation of this practice of reusing single-use medical devices would stop potential cross-infection, but this would cost an estimated $2.5 million or more per case prevented. MJA 1996; 164: 533-536 Introduction Current guidelines generally recommend that medical devices labelled "single use only" should not be reused, but controversy arises because of their high cost and the belief that using them once only is wasteful as well as environmentally unsound.1,2 The United States Food and Drug Administration (FDA) maintains that there is a lack of data to support the general reuse of disposable devices.3 They consider that an institution or a practitioner reusing a disposable medical device should be able to demonstrate that it can be adequately cleaned and sterilised; that its physical characteristics or quality will not be adversely affected by the cleaning/sterilising process; and that the device will remain safe and effective for its intended use. In addition, the FDA believes that institutions or practitioners who reuse devices must bear full responsibility for their safety and effectiveness.3The Australian Confederation of Operating Room Nurses (ACORN),4 the Federation of Sterilising Research and Advisory Councils of Australia (FSRACA)5 and the Medical Industries Association of Australia (MIAA)6 strongly oppose the reuse of "single use only" medical devices. The Commonwealth, New South Wales, Queensland and Victorian health departments have all made recommendations against reuse,7-11 although most departments implicitly acknowledge that it occurs and they recommend guidelines for reuse similar to those of the FDA. Many refer to requirements of the Code of Good Manufacturing Practice (GMP) of the Therapeutic Goods Act 1989 (Cwlth).12 However, given the stringent quality control procedures, documentation and required sampling numbers of the GMP code, reuse of single-use devices in hospitals would not comply with GMP requirements. Despite these directions and recommendations by regulatory authorities, there is anecdotal evidence that reuse occurs frequently in the belief that it saves money. However, for most devices the total costs of reusing have either not been calculated or do not take into account staff time and potential legal liabilities; reprocessing can at times be more expensive than purchasing replacements. In view of the controversy surrounding this subject, and the lack of data, we aimed to determine both the extent of reuse of single-use medical devices in Australian hospitals and the perceived problems associated with this practice. Methods In August 1994 we sent a questionnaire to all Australian hospitals with 45 beds or more where medical or surgical procedures were performed; 419 hospitals were identified (208 with < 100 beds, 147 with 100-300 beds, 49 with 300-600 beds, and 15 with > 600 beds).13 If after three months no reply had been received, individual responses were sought from those infection control practitioners in the non-responding institutions who were known personally to one of the authors. Replies were sought until the end of March 1995. All respondents were given the option of returning the questionnaire anonymously and were assured that no identifiable data from their hospital would be released. Questionnaire As well as information about frequency of reuse of single-use medical devices, the three-page questionnaire asked about: location of the hospital; the hospital size and type; specific details about cleaning and sterilisation methods for reused devices; and any change in hospital policy for reuse of single-use devices occurring in the previous 12 months, the reasons for any changes and whether the publicity from documented patient-to-patient transmission of HIV and hepatitis C in Australia14-16 had influenced any changes in practice. Respondents were also asked whether they were aware of any cross-infection resulting from reuse of single-use medical devices. To questions about reuse of a list of medical devices that we considered had a high potential for reuse, respondents could answer "yes", "no" or "not used in this hospital". Details were requested from all areas of the hospital that may have been reusing. Specific areas and devices mentioned included: general surgery (diathermy pencils, other items); laparoscopic surgery (scissors, forceps, other items); gastroenterology -- endoscopic retrograde cholangiopancreatography (ERCP) (cannulas, stone-removing baskets, balloon dilators); gastroenterology -- colonoscopy (diathermy snares, sclerosing needles); gastroenterology -- endoscopy (upper gastrointestinal tract) (sclerosing needles, cytology brushes, other items); imaging (angiography catheters, other items); cardiology (cardiac catheters, pacing electrodes, other items); oncology (bone marrow trephine sets). Details of devices reused from other areas were also requested. We sought information only on devices labelled "single use only" and used in sterile sites. Devices that were used in non-sterile sites (e.g., in gastroenterology procedures) were included if the device was used to breach a mucosal surface (e.g., a sclerosing needle or diathermy snare) and therefore entered a sterile site. Definitions of cleaning/sterilising Physical cleaning may not remove all the biofilm, endotoxins and chemical residue from medical devices. If all organic material is not removed subsequent sterilisation may be compromised. Therefore, "satisfactory cleaning" required the use of ultrasonics and/or the use of a brush, detergent and a proteolytic enzyme. "Satisfactory sterilisation" required either autoclaving or "gassing" with ethylene oxide. Because reusing these devices entails entry to sterile sites, glutaraldehyde or other chemical disinfectants were not regarded as achieving sterilisation. These agents do not achieve sterilisation without very long contact times and there are organisms resistant to these agents. Examination of devices A visual examination was made of the structure of the 14 medical devices named above to assess potential problems with cleaning. Results Reuse of medical devices Of 419 hospitals sent the questionnaire, responses were received from 168 (40%). Of these hospitals, 64 (38%) were reusing medical devices. Thirty-three other hospitals were no longer reusing at the time of our survey but had been doing so 12 months previously. Twenty-one of the 64 hospitals reported that they had reduced the number of devices being reused. Overall, 97 of 168 hospitals (58%) either were reusing devices at the time of the survey or had been doing so 12 months previously. Sixty-two of the reports were returned anonymously. In 32 of these 62 hospitals (56%) reuse was occurring at the time of the survey or 12 months previously. Large metropolitan public hospitals (9/14; 64%) were more likely to reuse these devices (Box 1). Cross-infection No institutions reported any cross-infection caused by reuse of single-use medical devices in sterile sites. Cleaning and sterilising The cleaning and/or sterilisation processes in six hospitals were regarded as unsatisfactory. Twenty other hospitals reusing medical devices provided insufficient information on cleaning and sterilising. For 38 hospitals (59%) we considered that both cleaning and sterilisation were satisfactory. Infection control committees One hundred and nineteen respondents commented that their infection control committees were concerned about the reuse of medical devices; 20 committees were not concerned (including eight committees at whose hospital reuse was occurring). In 26 hospitals the infection control committee had recommended that reuse of single-use devices should not occur, but reuse was still occurring. At 20 hospitals, infection control committees thought reuse appropriate in some instances, but no reuse was occurring in their hospitals. Altogether, 101 infection control committees had recommended against the reuse of single-use medical devices. Fifty-two hospital committees had stated that single-use devices could be used under defined circumstances. Fifteen hospitals did not supply information on this question. Factors influencing reuse The main reason provided for reuse was cost saving. Other reasons given were waste minimisation and environmental concerns. At 45 hospitals the adverse publicity surrounding documented patient-to-patient transmission of HIV and hepatitis C in Australia14-16 had resulted in a decrease in both the types of devices reused and the overall incidence of reuse. Twenty-two hospitals had discontinued reuse altogether. The main medical devices that are being reused are listed in Box 2. Examination of devices We were able to examine all 14 of the medical devices named in the questionnaire (see Methods); 13 of these probably could not be adequately cleaned because they had either a complex structure or small hollow lumens or crevices. Only pacemaker electrodes appeared to us to be readily cleanable. Discussion Reuse of medical devices Reuse of single-use medical devices was a frequent practice in the Australian hospitals responding to our questionnaire, and it was more common in large metropolitan public hospitals. A Canadian study (examining reuse of all single-use devices, not just those used in sterile sites) also found more reuse in large hospitals.2 A recent draft report from the National Health and Medical Research Council (NHMRC) indicated that all 11 hospitals surveyed reused medical devices labelled as "single use only".17 Medicolegal implications and the media, however, appear to have had a major impact on reuse of single-use medical devices. Recent adverse publicity appears to have greatly influenced hospital practice, especially over the past one to two years. We believe our study underestimates the extent of reuse in Australia. The questionnaires were sent to infection control practitioners because of their knowledge and current understanding of the problem of reuse of single-use devices. We were surprised, however, that some institutions with well established infection control departments did not respond to our survey. This may be because of difficulty obtaining this information in large hospitals (with many different departments involved), or because of concerns about litigation and possible adverse publicity. Many questionnaires were returned with the proviso that the hospital's identity should remain strictly confidential. Although large metropolitan teaching hospitals were under-represented among respondents, trends indicated that expensive devices (such as cardiac catheters and electrophysiology catheters) are more likely to be reused in these hospitals. Both reports in the literature and informal sources (e.g., media reports) suggest that these devices are frequently reused.18-20 Cleaning and sterilisation Provided an instrument can be satisfactorily cleaned and sterilised, it should not transmit infection and it does not matter that it is labelled single-use only. However, the physical characteristics (e.g., of the plastic) may not withstand cleaning and sterilising, making the device less safe to use. Any devices with hollow lumens or crevices, or those that cannot be disassembled for cleaning, are very difficult to clean and sterilise reliably, either by autoclaving or with ethylene oxide. In our study, a number of medical devices for which reuse appeared reasonable at first (e.g., single-use diathermy pencils) were found on closer examination to have spring-loaded buttons and crevices that would be difficult to adequately clean, particularly if contaminated with blood. Most disposable laparoscopic equipment appears to be very difficult to adequately clean, and most cannot be autoclaved because it is made of heat-sensitive materials. Ethylene oxide is less satisfactory than heat because it is less likely to penetrate hardened vegetative or protein matter (possibly harbouring microorganisms) remaining on inadequately cleaned medical devices. Other studies suggest that even when our requirements for "satisfactory cleaning" are followed, organic material frequently remains on these devices.21 Our study looked only at medical devices labelled "single use" and used in sterile body sites, but some of our reservations about devices whose design compromises cleaning are also valid for devices labelled reusable (e.g., laparoscopic equipment). Recommendations for reuse The divergent views of infection control committees and hospital practice found in our survey reinforce our view that it is difficult or impossible for individual hospitals to assess in isolation whether reuse of single-use medical devices is safe and cost efficient. Our recommendations to deal with this dilemma are given in Box 3. We concur with the recent NHMRC draft report17 recommending that, if the Australian health ministers allow continuation of reuse, the institutions seeking to process devices for reuse should be licensed and comply with specific national standards and procedures, and that the cleaning/sterilising process should be cost effective.17 Cross-infection The frequency of cross-infections occurring from reuse of single-use medical devices is not known. There are no studies that address the "harmfulness" of reuse in a rigorous fashion (i.e., evidence-based medicine). No cases were reported in our study and there are none to our knowledge reported in the literature. If cross-infection does occur, it is likely to be infrequent. It may also go undetected because of the long incubation period and the asymptomatic nature of many blood-borne viral infections. The number of cases of cross-infection occurring will depend on the prevalence of infection in the community, the risk of transmission and the number of procedures performed (Box 4). Unfortunately, we do not have information on all these factors. The risk is likely to be low and would be expected to be much less than that for a needlestick injury. The risk of transmitting HIV with a percutaneous injury when the source person is infected with HIV is about 1/300.22 Other viruses such as hepatitis B have much higher transmission rates,22 but, considering that reused single-use devices are cleaned and disinfected and that cross-infections have not been documented, the risk rate is likely to be 1/500 or less (and possibly close to zero). If one million procedures are carried out in Australia each year with reused single-use medical devices and we assume a 2% prevalence of blood-borne infections (our estimate for the prevalence of blood-borne infections in the Australian patient population), then 40 infections will be transmitted. Costs and cost benefit The total extra costs involved in ceasing reuse are not known. One of the hospitals participating in the survey stopped reusing "single use only" medical devices which enter sterile sites. The estimated budget increases for consumables in that hospital's Gastroenterology Endoscopy Unit and Radiology Unit were $192 000 per year and $142 000 per year, respectively. Estimates have been made of additional costs of at least $100 million per year if reuse is to cease in Australia.20 Therefore, in Australia the maximum cost is likely to be $2.5 million per infection prevented. If the risk rate is much lower than 1/500 then the cost per infection prevented will be much higher. Another factor to be taken into account is how many times a device is reused. If it is reused on 20 different patients, the cumulative risk of the device becoming contaminated with a blood-borne infection will be higher than in our estimates. Banning the reuse of all "single-use" invasive medical devices will thus have major implications for health care costs, and it is unlikely that governments and third parties will contribute this extra funding. This may result in fewer diagnostic or therapeutic procedures being carried out, longer waiting lists for procedures, and the possibility of adverse outcomes for patients because procedures are not performed at the appropriate time. In addition to the direct dollar costs, these potential negative outcomes (associated with complete banning of reuse of single-use devices) need to be balanced against the infection risks and the risks of malfunction associated with reprocessing of these devices. The recent NHMRC report also stresses the need for extra resources if the Australian health ministers ban reuse of single-use devices.20 Acknowledgements We would like to thank all the infection control practitioners who provided information for our survey. We would also like to thank Dr Gerda Mark, Ms Sharon McAuliffe and Mr Martin Dwyer for their thoughtful critique of the information. To top of article Register to be notified of new articles by email - - ©MJA1996 See also articles by Brook and Woollard References Lacroix D, Lucas H, Stewart I. Anxiety, misinformation and greed. Aust Nurs J 1994; 2: 17-20. Campbell BA, Wells GA, Palmer WN, Martin DL. Reuse of disposable medical devices in Canadian hospitals. Am J Infect Control 1987; 15: 196-200. United States Food and Drug Administration. Compliance Policy Guide. Reuse of medical disposable devices. 7124.6. Washington, DC: FDA, 24 Sept 1987. Australian Confederation of Operating Room Nurses policy statement. Reuse of single use items. ACORN J 1992; Dec: 3. Federation of Sterilising Research and Advisory Councils of Australia (FSRACA) policy statement: reuse of single use items. Melbourne: FSRACA, 14 Feb 1994. Medical Industry Association of Australia (MMIA). Statement of Industry Policy: reuse of single-use medical devices. Sydney: MMIA, 6 Aug 1991. Adams A (Chief Medical Adviser, Commonwealth Department of Human Services and Health). Communication: reuse of single-use devices. Canberra: DHSH, 1 Aug 1994. de Souza D. Reuse of medical devices [letter]. Med J Aust 1984; 141: 394. 9. Owen JW (Director-General, New South Wales Health). Reuse of single use medical devices. Sydney: NSW Health, 22 Jul 1994. (Draft Circular 83/62.) Lange D (Chief Health Officer, Queensland Health Sterilising Services). The reuse of single use medical devices. Brisbane: Queensland Department of Health, 5 August 1993. (Medical Circular No. 16/93.) Lynch P (Acting Chief Medical Officer, Victorian Department of Health and Community Services). Re-use of disposable single use items. Melbourne: DHCS, 29 January 1993. (Circular No. 2/1993.) Commonwealth of Australia. Therapeutic Goods Act. Canberra: AGPS, 1989. Hospital and health services yearbook and equipment catalogue, 14th ed. Prahran, VIC: Peter Isaacson Publications, 1990. Chant K, Lowe D, Rubin G, et al. Patient to patient transmission of HIV in private surgical consulting rooms. Lancet 1993; 342: 1548-1549. Collignon P. Patient to patient transmission of HIV. Lancet 1994; 343: 415. Chant K, Kociuba K, Munro R, et al. Investigation of possible patient-to-patient transmission of hepatitis C in a hospital. NSW Public Health Bull 1994; 5: 47-51. Dunnigan A, Roberts C, McNamara M, et al. Success of reuse of cardiac electrode catheters. Am J Cardiol 1987; 60: 807-810. Anderson F, Heale, J Alison, Harper RW. Feasibility and cost effectiveness of reuse of electrophysiology electrode catheters [abstract]. The Cardiac Society of Australia and New Zealand Meeting 1994. Aust N Z J Med 1994; 24: 653. Myburgh RE, Eldridge KL, Weerasooriya HR, Davis MJE. Reuse of electrophysiologic and ablation catheters -- feasibility and costs [abstract]. The Cardiac Society of Australia and New Zealand Meeting 1994. Aust N Z J Med 1994; 24: 655. National Health and Medical Research Council. Report of the NHMRC Expert Panel on the Re-use of Medical Devices Labelled as Single Use. Draft report. Canberra: NHMRC, 26 Oct 1995. Atkins, R. Examination of single use items by scanning electron microscopy. J GENSA 1995; 5: 13-15. Henderson DK. HIV-1 in the health care setting. In: Mandell GL, Bennett JE, Dolan R, editors. Principles and practice of infectious diseases, 4th ed. New York: Churchill Livingston, 1995: 2632-2656. (Received 27 Nov 1995, accepted 21 Mar 1996) Authors details Woden Valley Hospital, Canberra, ACT. Peter J Collignon, FRACP, FRCPA, Microbiologist and Infectious Diseases Physician; and Head, Infectious Diseases Unit; Elaine Graham, RN, CIC, Clinical Nurse Consultant, Infection Control; Dianne E Dreimanis, RN, RM, BHSc(Nursing), Acting Clinical Nurse Consultant, Infection Control. No reprints will be available. Correspondence: Dr P J Collignon, Infectious Diseases Unit, Woden Valley Hospital, PO Box 11, Woden, ACT 2606. To top of article - - ©MJA1996 See also articles by Brook and Woollard < URL: http://www.mja.com.au/> © 1996 Medical Journal of Australia.

Peter J Collignon · Elaine Graham · Dianne E Dreimanis

General medicine 6 May 1996 Free

Reuse of single-use medical devices: National Health and Medical Research Council deliberations

Reuse of single-use medical devices: NHMRC deliberations Whether reuse is banned or condoned practices must change This article was published in the 6 May issue of The Medical Journal of Australia. Readers may print a single copy for personal use. No further reproduction or distribution of the articles in whole or in part should proceed without the permission of the publisher. For copyright permission, contact the Australasian Medical Publishing Company See also articles by Collignon and Woollard - - ©MJA1996 The reuse of medical devices labelled "single use only" is widespread in Australian hospitals, as it is in hospitals throughout the developed world. The practice generates both strong support and strong opposition among different sectors of the health care community, and there has been vigorous public debate about it in Australia.1,2 There are numerous reports of adverse outcomes associated with reuse of single-use medical devices. These are not restricted to infection, but include physical trauma, device breakage and toxic reactions.3-5 However, there are few systematic data examining reuse of medical devices or outcomes of this reuse in Australia, and the report by Collignon et al. in this issue of the Journal (page 533) is a welcome addition. Some professional groups1,2and, more recently, the public6 have raised serious concerns about the safety and efficacy of reuse. The National Health and Medical Research Council (NHMRC) established an expert panel in August 1994 to examine the policies, practices and standards which apply to reuse in Australia, and to make recommendations on future management of reuse.7 Recognising the lack of systematic data, the panel commissioned a survey to document the practices and standards for reuse of medical devices within 11 large public and private hospitals across Australia. The survey showed that, while reuse had decreased in recent years, hospital policies for reuse were often inconsistent with practices; standards for cleaning and sterilisation before reuse were unsatisfactory; quality assurance procedures for these processes were inadequate; and patients were not fully informed of hospital policies and practices for reuse. In almost all cases, the hospitals cited budgetary pressures as the reason for reuse. A major part of the NHMRC study was a physical and microbiological assessment, never undertaken before, of a selection of commonly reused devices. Observed deficiencies included physical damage, evidence of contamination and, in one case, bacterial growth (i.e., many of the processed devices were unsuitable for reuse). The results of this assessment made a significant contribution to the panel's further deliberations and recommendations. The NHMRC expert panel considered a range of options and concluded that the current practice cannot be condoned. Two basic principles underpinned the panel's decisions. Firstly, the dichotomy between policy and practice must be addressed; and, secondly, decisions must always be made on the basis of the most cost-effective allocation of scarce resources. The issue ultimately rests with the responsible health ministers. If they decide that the practice of reuse cannot be endorsed, the following consequences must be recognised and acceptedATBody1stpr:* Funding will need to be increased to allow for purchase of new devices, or a reduction in services will result. * Some form of regulation will be required to ensure compliance (this will apply also if reuse is endorsed). Other principles relate to reuse if it is condoned. * Any decision to reuse must be based on an assessment of the costs and benefits of reuse. If there is no significant economic benefit, reuse should not be contemplated. Economic assessment needs to be rigorous and to include adequate provision for quality assurance monitoring. * Processing for reuse needs to be of a standard which ensures the cleanliness, sterility and structural integrity of the devices. This requires that institutions processing devices for reuse must apply stringent quality assurance procedures to ensure their safety and integrity. The standards required must approach those of the Therapeutic Goods Administration's Code of Good Manufacturing Practice. Regulatory frameworks may be needed to ensure that these standards are met. * Institutions and practitioners who reuse devices must carry the responsibility for ensuring the quality and safety of those devices. * Patients' right to information about an institution's policy for reuse must be addressed. This may prove crucial if reuse is ever an issue in a personal litigation case. These principles for devices labelled "single use only" apply equally to devices designated for reuse. Indeed, data before the NHMRC expert panel suggested that shortcomings in cleaning and sterilising processes apply generally. The panel's draft report and recommendations8 are being revised in the light of public submissions, and the final report is expected to be released later this year. In Canada there has also been a lively debate on reuse of single-use medical devices,8 and for some time there have been strong proponents for reuse.9 The NHMRC panel's conclusions, however, parallel a recent policy statement by the Canadian Healthcare Association.10 Christopher W Brook Chair, NHMRC Expert Panel on the Re-use of Medical Devices Labelled as Single Use Director, Public Health, Department of Health and Community Services, Melbourne, VIC Australian Nurses Federation. Multiple use of single use items -- the Nurses responsibility. Abstracts. Heidelberg Repatriation Hospital, July 1994. Melbourne: ANF, 1994: 15p. Medical Industry Association of Australia. Reuse of single-use medical devices. Conference proceedings. University of New South Wales, August 1991. Sydney: MIAA, 1991: 57p. Jacobsen JA, Schwartz CE, Marshall HW, et al. Fevers, chills and hypotension following cardiac catheterization with single and multiple use disposable catheters. Cathet Cardiovasc Diagn 1983; 9: 39-46. Kundsin RB, Walter CW. Detection of endotoxin on sterile catheters used for cardiac catheterization. Clin Microbiol 1980; 11: 209-212. Case report. MMWR Morb Mortal Wkly Rep 1982; 31: 290-291. Australian Broadcasting Corporation. Television program. 7.30 Report. 1994: 8 Sep. National Health and Medical Research Council. Expert Panel Report on the Re-use of Medical Devices Labelled as Single Use. Draft report. Canberra: NHMRC, 26 Oct 1995. Reuse of disposable medical devices. Proceedings of the Fourth Canadian Co-ordinating Office for Health Technology Assessment. Regional Symposium; 1994 Oct; Montreal, Canada. Montreal: CCOHTA, 1994: 47p. The reuse of single-use catheters. Report submitted to: Ministre de la SantŽ et des Services Socieux du Quebec par le Conseil d'Žvaluation des Technologies de la SantŽ. July 1993. Montreal: CETS: 1993: 65p. Canadian Healthcare Association. The reuse of single-use medical devices. Guidelines for healthcare facilities. Ottawa: CHA Press, 1996. oSee also articles by Collignon and Woollard - - To top of article - ©MJA1996 < URL: http://www.mja.com.au/> © 1996 Medical Journal of Australia.

Christopher W Brook

General medicine 6 May 1996 Free

Reuse of single-use medical devices: who makes the decision?

Reuse of single-use medical devices: who makes the decision? The controversy can be resolved by identifying the real risks of cross-infection This article was published in the 6 May issue of The Medical Journal of Australia. Readers may print a single copy for personal use. No further reproduction or distribution of the articles in whole or in part should proceed without the permission of the publisher. For copyright permission, contact the Australasian Medical Publishing Company See also articles by Collignon and Brook - - ©MJA1996 The transmission of infectious agents between patients during medical procedures is a matter of substantial public concern1 after two widely reported incidents of transmission of HIV infection (in a doctor's office and in a dental practice), and recent episodes of hepatitis B and C transmission.2,3 The usual explanation for these episodes is a breakdown of standard infection control procedures. These reports have increased pressure on Australian hospitals and doctors to cease the practice of reusing medical devices labelled by the manufacturers as "single use only". The Commonwealth and most State health departments also recommend that this practice should cease. The National Health and Medical Research Council (NHMRC) established an expert panel on "Re-use of medical devices labelled as single use" and recently has circulated a draft report.4 This recommends either a blanket ban on the reuse of such devices or the establishment by the Therapeutic Goods Administration of "a system for the formal licensing of entities wishing to process devices labelled as single use". I believe this could effectively prevent any such reuse. Needless to say the Medical Industries Association of Australia strongly opposes the reuse of these items. With such formidable opposition it should come as a surprise to many that reuse of single-use medical devices is widespread in Australian hospitals. Reuse was occurring in all 11 hospitals surveyed by the NHMRC panel, and Collignon et al. in this issue of the Journal (page 533) report that 64 of 168 hospitals responding to their survey were currently reusing single-use items; another 33 hospitals had been doing so 12 months previously. With only a 40% response to their survey, the authors believe that they have probably underestimated the extent of reuse. The results of these surveys indicate a rebellion against expert advice. The rebellion extends to the pages of this Journal, with a recent editorial advocating reuse of cryoprobe tips after mechanical cleaning and glutaraldehyde soaking.5 Australian hospitals are reusing a wide range of equipment, including cardiac pacing electrodes, diathermy pencils and colonoscopy snares. Reuse of cardiac catheters has been reported in Australia6 and reuse of angioplasty balloons is common in other countries and has been reported to be safe.7 The explanation for this resistance by doctors and hospitals against expert opinion and direction from higher authorities is based on two important factors: firstly, there are apparently no reported cases in the medical literature of transmission of infection between patients as a result of the reuse of single-use medical devices; and, secondly, in the absence of any demonstrated adverse effects on patients, hospitals and doctors are not prepared to divert funds from other areas of medical care. Collignon et al. estimated that somewhere between zero and 40 infections per year may be transmitted as a result of procedures involving reuse of single-use medical devices in Australia, although it is not clear that cessation of reuse would eliminate these potential infections. They also estimated that it would cost an extra $100 million per year (the total annual research grant allocation by the NHMRC is $142 million!) if reuse of medical devices were to cease, and that preventing one new infection (and many of these will be benign) would cost at least $2.5 million, and probably much more. When there are strongly conflicting views on the best way to provide medical care, a common underlying feature is absence of data. The appropriate professional response is to obtain such data. Concerns about possible transmission of infectious agents as a result of medical procedures would be addressed by establishing an Australian study; for example, this could involve serological testing of large numbers of patients before and after a range of invasive procedures to look for evidence of seroconversion for hepatitis agents. In this way the real risk of transmission could be identified. In the meantime, what should be done about reuse? Some (especially legal advisers) would advocate a perfect standard, requiring absolute proof of safety for every aspect of medical care. Only a minority of the processes involved in medical care have passed such a test. A more sensible approach might be for all doctors involved in reuse of single-use items to re-examine their own activities to ensure that they comply as far as practicable with current guidelines. If health care professionals believe in "evidence-based medicine" they should add their voices to the call for a proper study in this area before any firm recommendations are made by bodies such as the NHMRC. Keith Woollard Cardiologist St John of God Medical Clinic Murdoch, WA Robinson M. The patient's right to know. Sydney Morning Herald 22 Feb 1996: 15. Tedder RS, Zukerman MA, Goldstone AH, et al. Hepatitis B transmission from contaminated cryopreservation tank. Lancet 1995; 346: 137-140. Chant K, Kociuba K, Munro R, et al. Investigation of possible patient-to-patient transmission of hepatitis C in a hospital. NSW Public Health Bull 1994; 5: 47-51. National Health and Medical Research Council. Report of the NHMRC Expert Panel on Re-use of Medical Devices Labelled as Single Use. Draft report. Canberra: NHMRC, 26 Oct 1995. Tabrizi SN, Garland SM. Is cryotherapy treating or infecting? Med J Aust 1996; 164: 263-264. Dedman G, Hendricks R, Lane G, et al. Comparative costs of cardiac catheters -- a quality controlled assessment. Aust N Z J Med 1994; 24: 643. Burton J, Tymchak W, Dzavik V, et al. Cost of percutaneous revascularisation. Circulation 1995; 92(Suppl 1): 661. oSee also articles by Collignon and Brook - - To top of article - ©MJA1996 < URL: http://www.mja.com.au/> © 1996 Medical Journal of Australia.

Keith Woollard

Next Issue Volume 164 Issue 10

View more
Medicine and the community 9 September 1999 Free

Assisted reproduction: a reassuring picture

Gabor T Kovacs

Previous Issue Volume 164 Issue 8

View more
Editorials 15 April 1996 Free

Haemophilia -- darkest hours before the dawn

Alison M Street · Henry Ekert

Research 15 April 1996 Free

Suspected snakebite in children: a study of 156 patients over 10 years

Helen J Mead · George A Jelinek

For debate 15 April 1996 Free

Trauma in pregnancy and cerebral palsy: is there a link?

Marisa T Gilles · Eve Blair · Linda Watson · Nadia Badawi · Louisa Alessandri · Vivienne Dawes · Aileen J Plant · Fiona J Stanley

Subscribe to MJA email alerts

No spam, you can unsubscribe anytime you want.

By providing your information, you agree to our Terms of Use and our Privacy Policy.

Thanks for Subscribing! Tell us more

Your email updates will use your name.

Good one! Your updates are coming

Thank you for subscribing to the MJA email alerts. Receive the latest content in your inbox.